Connect your AI

NeoGenomics NEO Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Quest DiagnosticsDGX

$65M+124%

Personalis, Inc.PSNL

$20.95M+17.8%

Guardant HealthGH

$3.65M+375%

Natera, Inc.NTRA

$3.86M+610%

GeneDx HoldingsWGS

$476K—

ImmunomeIMNM

$229K+7.5%

Other financials

Income statement

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NeoGenomics's stock issuance proceeds?: NeoGenomics (NEO) reported stock issuance proceeds of -$338K in Q1 2026.
How has NeoGenomics's stock issuance proceeds changed year-over-year?: NeoGenomics's stock issuance proceeds decreased by 135.6% year-over-year, from $949K to -$338K.
What is the long-term trend for NeoGenomics's stock issuance proceeds?: Over 4 years (2021 to 2025), NeoGenomics's stock issuance proceeds has grown at a -49.7% compound annual growth rate (CAGR), from $15.08M to $962K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.